Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Floods, Landslides Triggered By Heavy Rain In Afghanistan Leave 77 Dead In 10 days, Authorities Say - 2Figure out How to Track and Anticipate Future Cd Rates
- 3Data centers in space: Will 2027 really be the year AI goes to orbit?
- 4Former elite Australian soldier charged with Afghan war crimes
- 5Vote In favor of Your Favored Kind Of Organic product
- Fascinating Fishing Objections From Around The World
- Top German court to rule on claims by Wirecard shareholders
- First Houthi launch toward Israel since war began triggers alerts across the Negev
- Get away from the Tedious Drudgery: Go into Business Today!
- Staggering Spots to Stargaze All over the Planet
- A definitive Manual for the 5 Off-road Bicycles Available
- 'Seditious behavior': Trump accuses Democrats who made video reminding the military not to follow illegal orders of a crime — but is it?
- The Reduced Portage Horse: An Inheritance Reconsidered for Present day Experience
- WHO issues guidance on GLP-1 drugs for obesity
